Vascular changes and black hole phenomenon after coronary brachytherapy: a pathologically distinct entity

Area of Science:

• Cardiovascular medicine
• Interventional cardiology
• Biomedical engineering

Background:

• Coronary brachytherapy effectively treats in-stent restenosis but can lead to unique vascular wall changes.
• Restenotic tissue after brachytherapy exhibits an acellular, echolucent appearance on intravascular ultrasound, termed the "black hole" phenomenon.

Purpose of the Study:

• To investigate the characteristics of restenotic tissue following coronary brachytherapy and drug-eluting stent implantation.
• To explore the potential classification of neointima based on its formation after different stenting procedures.

Main Methods:

• Review of intravascular ultrasound findings in patients treated with coronary brachytherapy and drug-eluting stents.
• Analysis of the composition and characteristics of restenotic tissue in different clinical scenarios.

Main Results:

• The "black hole" phenomenon is characteristic of post-brachytherapy restenosis and is less common after drug-eluting stent implantation, except in specific cases like prior brachytherapy or saphenous venous graft stenosis.
• A proposed classification of neointima as primary (bare metal), secondary (brachytherapy or DES), and tertiary (combined) may aid research and clinical understanding.
• Unique vascular changes are observed after both brachytherapy and drug-eluting stent placement.

Conclusions:

• The "black hole" phenomenon likely results from modified neointima, but its exact nature (autolysis vs. new formation) requires further investigation.
• Neointima formation differs between brachytherapy and drug-eluting stents, necessitating a nuanced approach to understanding restenosis.
• Further research is needed to clarify the similarities and differences in vascular wall changes and restenosis after brachytherapy and drug-eluting stent placement.